| GAFFX | VMGAX | GAFFX / VMGAX | |
| Total Expense Ratio | 0.29 | 0.05 | 580% |
| Annual Report Gross Expense Ratio | 0.29 | 0.05 | 580% |
| Fund Existence | 9 years | 18 years | - |
| Gain YTD | 5.343 | 5.901 | 91% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 5000000 | 20% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 338B | 35B | 966% |
| Annual Yield % from dividends | 0.51 | 0.32 | 158% |
| Returns for 1 year | 9.43 | 25.44 | 37% |
| Returns for 3 years | 47.75 | 93.92 | 51% |
| Returns for 5 years | 19.72 | 99.75 | 20% |
| Returns for 10 years | N/A | 417.23 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GREZX | 10.20 | 0.01 | +0.10% |
| GuideStone Funds Global Rl Est Secs Inv | |||
| STRBX | 22.41 | -0.26 | -1.15% |
| Sterling Capital Behav Sm Cp Val Eq R6 | |||
| FFACX | 17.98 | -0.36 | -1.96% |
| Franklin Global Allocation C | |||
| FTDZX | 179.63 | -4.30 | -2.34% |
| Franklin Biotechnology Discovery Adv | |||
| VGIAX | 117.18 | -3.54 | -2.93% |
| Vanguard Growth & Income Adm | |||